THERACLION (ALTHE.PA) Forecast, Price Target & Analyst Ratings

EPA:ALTHE • FR0010120402

Current stock price

0.4975 EUR
+0.03 (+5.85%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for THERACLION (ALTHE.PA).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of €0.50 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALTHE Current Analyst RatingALTHE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ALTHE Historical Analyst RatingsALTHE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
ALTHE.PA was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ALTHE.PA.
In the previous month the buy percentage consensus was at a similar level.
ALTHE.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024
Revenue
YoY % growth
ALTHE.PA revenue by date.ALTHE.PA revenue by date.
1.236M
-16.58%		1.822M
47.49%		830.2K
-54.44%
EBITDA
YoY % growth
ALTHE.PA ebitda by date.ALTHE.PA ebitda by date.
-6.198M
-39.46%		-510.7K
91.76%		-5.995M
-1,073.90%
EBIT
YoY % growth
ALTHE.PA ebit by date.ALTHE.PA ebit by date.
-6.307M
-39.09%		-3.153M
50.02%		-6.819M
-116.30%
Operating Margin
ALTHE.PA operating margin by date.ALTHE.PA operating margin by date.
-510.51%-173.01%-821.38%
EPS
YoY % growth
ALTHE.PA eps by date.ALTHE.PA eps by date.
N/A
-100.00%		N/A
100.00%		N/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALTHE.PA Yearly Revenue VS EstimatesALTHE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTHE.PA Yearly EPS VS EstimatesALTHE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2024 0 -0.2 -0.4 -0.6 -0.8 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

THERACLION / ALTHE.PA Forecast FAQ